+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fanapt"

Bipolar Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Bipolar Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 85 Pages
  • Global
From
From
Antipsychotic Drugs: Technologies and Global Markets - Product Thumbnail Image

Antipsychotic Drugs: Technologies and Global Markets

  • Report
  • September 2018
  • 174 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Fanapt is a medication used to treat schizophrenia in adults. It is a selective dopamine D2 receptor antagonist, which works by blocking the action of dopamine in the brain. It is used to reduce the symptoms of schizophrenia, such as hallucinations, delusions, and disorganized thinking. Fanapt is also used to treat schizoaffective disorder, a condition that combines features of both schizophrenia and a mood disorder. The Fanapt market is a subset of the larger mental disorders drugs market. It is a rapidly growing market, driven by the increasing prevalence of mental health disorders and the need for effective treatments. The market is highly competitive, with a number of companies offering similar products. Some of the companies in the Fanapt market include Novartis, Otsuka Pharmaceuticals, and Sunovion Pharmaceuticals. Show Less Read more